Jaguar Animal Health, Inc., a development-stage animal health company, focuses on developing and commercializing gastrointestinal products for companion and production animals, foals, and high value horses. The company's lead prescription drug product candidate includes Canalevia, a canine-specific formulation of Crofelemer for the treatment of CID and general acute watery diarrhea in dogs. It is also developing Crofelemer to treat acute colitis in horses and general acute watery diarrhea in cats; Neonorm, an enteric-coated tablet for scours in preweaned dairy calves, as well as other animal species, such as horses, goats, and sheep; and other product candidates, including Virend and NP-500. The company was founded in 2013 and is headquartered in San Francisco, California.
+30% move this morning Jaguar Animal Health, Inc. (JAGX) (“Jaguar” or the “Company”), an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value horses, announced additional topline results today from its study conducted in conjunction with researchers from Cornell University College of Veterinary Medicine (“Cornell”) to evaluate the efficacy of the prophylactic use of a second-generation, powder formulation of Neonorm™ Calf, administered in liquid, on naturally occurring diarrhea and dehydration in preweaned dairy calves.
Maybe this news will get it back up to June last year $2+ ranges? Stockholders of Jaguar Animal Health and Napo Pharmaceuticals Vote to Approve Merger -https://finance.yahoo.com/news/stockholders-jaguar-animal-health-napo-000800443.html Adding and fwtiw - just checked b/c know pet related stock along with insider buying is what initially got me interested and insider is still holding 160K @ $2.50.
I can’t wait to see the L2 action PM in a few hours...Over .2385 there's no resistance on the charts until .40 let see where bids enter